Activation of WNT pathway via gsk3 inhibitors for a possible therapy in Alzheimers disease

dc.contributor.guide	Praveen T.K.
dc.coverage.spatial	Pharmacy
dc.creator.researcher	Magham Sai Varshini
dc.date.accessioned	2025-02-05T11:37:42Z
dc.date.available	2025-02-05T11:37:42Z
dc.date.awarded	2024
dc.date.completed	2024
dc.date.registered	2021
dc.description.abstract	Available
dc.description.note	Summary 104p, References 105-114p
dc.format.accompanyingmaterial	CD
dc.format.dimensions	3
dc.format.extent	1-118p
dc.identifier.researcherid
dc.identifier.uri	http://hdl.handle.net/10603/620233
dc.language	English
dc.publisher.institution	Colleges of Pharmacy
dc.publisher.place	Mysore
dc.publisher.university	JSS Academy of Higher Education and Research
dc.relation	183
dc.rights	university
dc.source.university	University
dc.subject.keyword	Alzheimer s disease, polysorbate 80, brain, Indirubin-3 oxime, Okadaic acid
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Pharmacology and Pharmacy
dc.subject.keyword	Pharmacology and Toxicology
dc.title	Activation of WNT pathway via gsk3 inhibitors for a possible therapy in Alzheimers disease
dc.title.alternative
dc.type.degree	Ph.D.